Candidiasis of other urogenital sites
ICD-10 B37.6 is a billable code used to indicate a diagnosis of candidiasis of other urogenital sites.
Candidiasis of other urogenital sites refers to fungal infections caused by Candida species, primarily Candida albicans, affecting areas of the urogenital tract that are not classified under more specific codes. This condition can manifest in various forms, including vulvovaginal candidiasis, urethritis, and infections of the bladder or other urogenital structures. Symptoms may include itching, burning, abnormal discharge, and discomfort during urination or sexual intercourse. The risk of developing candidiasis increases in immunocompromised patients, such as those with HIV/AIDS, diabetes, or those undergoing immunosuppressive therapy. Diagnosis typically involves clinical evaluation and laboratory tests, including culture and sensitivity testing to identify the specific Candida species and determine antifungal susceptibility. Treatment usually involves antifungal medications, such as fluconazole or topical agents like clotrimazole, with the choice of therapy depending on the severity of the infection and the patient's overall health status. Proper management is crucial to prevent recurrent infections and complications, particularly in vulnerable populations.
Detailed clinical history, laboratory results, and treatment plans.
Patients with recurrent candidiasis, immunocompromised patients, and those with atypical presentations.
Documentation must clearly indicate the site of infection and any underlying conditions.
Urological evaluations, imaging studies if applicable, and treatment responses.
Men presenting with urethritis or bladder infections suspected to be candidiasis.
Ensure differentiation from other urogenital infections and document any relevant surgical history.
Used when a patient presents with symptoms of candidiasis and requires laboratory confirmation.
Document the reason for the culture and any prior treatments.
Infectious disease specialists may require additional details on the patient's history.
Common symptoms include itching, burning sensation, abnormal discharge, and discomfort during urination or sexual intercourse.
Diagnosis is typically made through clinical evaluation and confirmed with laboratory tests, including cultures to identify the specific Candida species.
Treatment options include antifungal medications such as fluconazole and topical agents like clotrimazole, depending on the severity and site of infection.
